Why Royal Dutch Shell Plc, AstraZeneca plc and Aggreko plc Should Lag The FTSE 100 Today

Royal Dutch Shell Plc (LON: RDSB), AstraZeneca plc (LON: AZN) and Aggreko plc (LON: AGK) all slide.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) is continuing its positive week, up another 21 points to 6,642 approaching midday for a gain of 87 points on the week so far. Today the index had been affected by mixed earnings reports, but has been buoyed by generally positive noises from the US Federal Reserve yesterday — growth is uncertain, but inflation is still low. The latest Chinese manufacturing figures remain upbeat too.

But which of today’s updates have held back the FTSE? Here are three that resulted in share price falls:

Royal Dutch Shell

Shares in Royal Dutch Shell slumped 115p (5%) to 2,204p this morning after first-half earnings, on a current cost of supplies (CCS) basis, fell 20% to $3.6bn — for Q2 itself, earnings crashed to $2.4bn from $6bn in the same quarter last year. Basic earnings per share (EPS) for the quarter, again at CCS, fell 21%, though the Q2 dividend was lifted 5% to 45 cents per ordinary share.

Chief executive Peter Voser said “Higher costs, exploration charges, adverse currency exchange rate effects and challenges in Nigeria have hit our bottom line. These results were undermined by a number of factors – but they were clearly disappointing for Shell“.

AstraZeneca

AstraZeneca reported a 4% fall in second-quarter revenue, to $6.23bn, with loss of exclusivity on several drugs knocking an estimated $500m off sales. Adjusted pre-tax profit for quarter fell 10% at constant exchange rates, with adjusted EPS down 21% to $1.20. For the half, pre-tax profit slipped 16% with EPS also down 21%.

The fall-off in revenue from traditional drugs was largely anticipated, and with plans for the future underway chief executive Pascal Soriot told us that “We continue to invest in distinctive science, our pipeline projects, products and key markets and our five key growth platforms delivered a double-digit increase in revenue contribution“.

Aggreko

Aggreko shares fell 105p (5.8%) to 1,676p, also on the release of second-half figures. In this case, the provider of power and temperature control equipment reported a rise in revenue, of 4% to £760m, but pre-tax profit slipped by 2% to £146m with EPS dropping 4% to 39.94p. At least the dividend was up, by 10% to 9.11p per share — a similar rise in the final dividend would give shareholders a modest 1.6% yield.

Despite these poorer-than-expected first-half figures, chief executive Rupert Soames seemed upbeat, saying “Our expectations for the full year remain unchanged“. The City is currently forecasting an 8% fall in EPS, with the shares on a forward P/E of 19.

Finally, reliable dividends can more than compensate for the day-to-day ups and downs of share prices. So how about a company that’s offering a 5% yield and which could be set for some nice share price appreciation too?

It’s the subject of our BRAND-NEW report, “The Motley Fool’s Top Income Share For 2013“, which you can get completely free of charge — but it will only be available for a limited period, so click here to get your copy today.

> Alan does not own any shares mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Forget Lloyds’ cheap share price! I’d rather consider this FTSE 100 bargain share

Lloyds' share price might appear too cheap to miss at first glance. But this FTSE-listed share could be a better…

Read more »

Market Movers

Down 6% today, is the BT share price gearing up for a larger fall?

Jon Smith points out why the BT share price has tumbled today, but flags up why the reasoning behind the…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

This FTSE 100 stock is down 25% from its 52-week high. Should I buy?

Analysts think the price-to-earnings ratio of this FTSE 100 stock could fall by half in the next two years if…

Read more »

Investing Articles

£10,000 invested in Nvidia stock just two weeks ago is already worth…

Nvidia stock's been making big losses and big gains so far in 2025, at least on paper. But long-term valuation…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Here’s why Lloyds shares have dipped sharply

Lloyds shares got a boost recently when the Treasury petitoned the Supreme Court to go easy on the car loan…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

A £10,000 investment in BAE Systems shares 5 years ago is now worth…

BAE Systems' shares have lifted off since the start of the decade. But can the FTSE 100 defence giant continue…

Read more »

Dividend Shares

£8,000 invested in high-yield dividend stocks could make this amount of passive income

Jon Smith explains how dividend shares with yields in excess of 8% can be used carefully in order to build…

Read more »

Investing Articles

£5,000 invested in Tesco shares 2 years ago is now worth…

Over the last two years, Tesco shares have provided investors with gains of around 30% per year when dividends are…

Read more »